Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VKTX

Viking Therapeutics Inc

May 12 • 12:00PM ET

30.92

-0.80 -2.53 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: GPCR RYTM ALT TERN MDGL

| Held by: VTI VB XBI VBK VXF SCHA IWR DFMC VHT IWD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.15	Insider Own	2.81%	Shs Outstand	115.89M	Perf Week	-1.25%
Market Cap	3.59B	Forward P/E	-	EPS next Y	-4.72	Insider Trans	-9.94%	Shs Float	112.85M	Perf Month	-11.69%
Enterprise Value	2.99B	PEG	-	EPS next Q	-1.26	Inst Own	63.07%	Short Float	20.07%	Perf Quarter	7.54%
Income	-472.33M	P/S	-	EPS this Y	-48.12%	Inst Trans	-1.33%	Short Ratio	9.00	Perf Half Y	-15.91%
Sales	0.00M	P/B	7.14	EPS next Y	0.12%	ROA	-64.04%	Short Interest	22.65M	Perf YTD	-12.11%
Book/sh	4.33	P/C	5.95	EPS next 5Y	-8.69%	ROE	-70.04%	52W High	43.15 -28.35%	Perf Year	9.25%
Cash/sh	5.19	P/FCF	-	EPS past 3/5Y	-52.71% -42.46%	ROIC	-94.11%	52W Low	22.96 34.67%	Perf 3Y	37.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.58% 5.03%	Perf 5Y	422.27%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-259.98%	Oper. Margin	-	ATR (14)	1.62	Perf 10Y	2434.30%
Dividend Ex-Date	-	Quick Ratio	5.72	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.77	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	5.72	EPS Q/Q	-236.44%	SMA20	-5.46%	Beta	0.69	Target Price	94.12
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-7.15%	Rel Volume	0.57	Prev Close	31.72
Employees	53	LT Debt/Eq	0.00	Earnings	Apr 29 AMC	SMA200	-5.51%	Avg Volume	2.52M	Price	30.92
IPO	Apr 29, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-40.43% -	Trades		Volume	600,979	Change	-2.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)